🔬 CYSTIC FIBROSIS & PANCREATIC FUNCTION

A silent challenge beyond the lungs.

Cystic fibrosis, also known as mucoviscidosis, is a rare hereditary genetic disorder that primarily affects the lungs and the digestive system.

It is caused by a mutation in the CFTR gene (Cystic Fibrosis Transmembrane Conductance Regulator), which leads to an abnormal regulation of salt and water in the cells.

This abnormality causes the production of thick and sticky secretions, particularly in the airways and the pancreas.

While CFTR modulators have transformed pulmonary outcomes, pancreatic insufficiency remains untouched .

🚨 Until now

EN311 marks a game-changing breakthrough. 

For the first time, there is a real and promising path toward restoring gastrointestinal function in people with CF.

Following outstanding preclinical results, EN311 has now advanced to Phase 2 clinical trials, marking a major milestone in its development and a key step toward therapeutic transformation.

🧬 From Deficiency to Efficiency: Rethinking Pancreatic Absorption with EN311

hashtag#CysticFibrosis hashtag#PancreaticHealth hashtag#DigestiveHealth hashtag#RareDisease hashtag#ClinicalResearch